Search Clinical Trials

Search results for

Treatment of Physician Choice (TPC) Following First-Line Treatment of Lenvatinib for uHCC

The primary objective of this study is to assess the safety and tolerability of subsequent Treatment of Physician's Choice (TPC) following the first-line Lenvatinib treatment…

Inotuzumab Ozogamicin & Frontline Chemo in Treating Young Adults with Newly Diagnosed B-Cell ALL

This partially randomized phase III trial studies the side effects of Inotuzumab Ozogamicin and how well it works when given with frontline chemotherapy in treating…

Two Doses of GSK2857916 in Subjects with Multiple Myeloma Who Have Failed Multiple Prior Treatments

Multiple Myeloma (MM) is an incurable malignancy and accounts for 1 percentage of all cancers and for 10% of all hematologic malignancies. Subjects with Relapsed/Refractory…

Phase 3 Randomized Placebo Controlled Clinical Trial of Donepezil - WF 97116

This study is to compare the safety and effects of Donepezil (Aricept) or if it decreases memory loss after receiving chemotherapy for breast cancer. A…

Work Ability in Young Adult Survivors (WAYS)

To document levels of labor force participation, occupation, educational attainment, and financial toxicity following cancer treatment in YA cancer survivors aged 25-34 years. This observational,…

Pegylated Liposomal Doxorubicin + Atezolizumab and/or Bevacizumab for Recurrent Ovarian Cancer

This randomized phase II/III trial studies how well Pegylated Liposomal Doxorubicin Hydrochloride with Atezolizumab and/or Bevacizumab work in treating patients with Ovarian, Fallopian Tube, or…

Ruxolitinib, Paclitaxel, & Carboplatin for Stage III-IV Epithelial Ovarian Cancer

This phase I/II partially randomized trial studies the side effects and the best dose of Ruxolitinib Phosphate when given together with Paclitaxel and Carboplatin and…

Financial Burden Assessment in Patients with Stage I-III Colon or Rectal Cancer Undergoing Treatment

This research trial studies the financial burden in patients with Stage I-III Colon or Rectal Cancer who are undergoing treatment. Collecting data from patients about…

DS-8201a in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer

Some HER-2 breast cancer patients do not respond or build resistance to current treatment. DS-8201a is a new experimental product that is a combination of…

Rucaparib vs. Physician’s Choice in Metastatic CRPC & Homologous Recombination Gene Deficiency

The purpose of this study is to determine how patients with metastatic castration-resistant prostate cancer, and evidence of a homologous recombination gene deficiency, respond to…